Clinical impact of Wnt5a expression on persistence of acute kidney injury in patients with urosepsis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, Jungho | - |
dc.contributor.author | Yoon, Yoosik | - |
dc.contributor.author | Oh, Dong-Jin | - |
dc.date.accessioned | 2024-07-22T07:01:20Z | - |
dc.date.available | 2024-07-22T07:01:20Z | - |
dc.date.issued | 2024-12 | - |
dc.identifier.issn | 0886-022X | - |
dc.identifier.issn | 1525-6049 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/75048 | - |
dc.description.abstract | Abnormal Wnt5a expression is associated with dysregulated inflammation and organ dysfunction. However, the effect of Wnt5a activation on the duration of organ dysfunction remains unclear. This prospective study investigated the association between Wnt5a levels and persistent acute kidney injury (AKI) in patients with urosepsis. Serum creatinine and Wnt5a levels were measured on days 1 and 5 and at discharge in 87 patients diagnosed with urosepsis. Patients with urosepsis were classified into an improving acute kidney injury (AKI) group and a persistent or worsening AKI group according to the AKI stage on days 1 and 5. AKI recovery was defined as a discharge-to-baseline serum creatinine ratio of <1.5. Twenty-eight patients with urosepsis (32.2%) had persistent or worsening AKI, and their Wnt5a levels were higher on days 1 and 5 and at discharge than those with improving AKI. The association between Wnt5a levels and persistent or worsening AKI was maintained after adjusting for age, sex, baseline serum creatinine levels, and disease severity. Moreover, elevated Wnt5a levels were associated with an increased risk of major adverse kidney events. High Wnt5a levels at discharge were associated with unrecovered AKI and participants with AKI recovery had a steeper Wnt5a slope over time than those without recovery, irrespective of age, sex, baseline serum creatinine level, or disease severity. Assessment of Wnt5a expression was helpful in predicting AKI persistence and adverse outcomes in patients with urosepsis. Therefore, Wnt5a may serve as a valuable bio-marker for identifying the risk of persistence of AKI. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Clinical impact of Wnt5a expression on persistence of acute kidney injury in patients with urosepsis | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/0886022X.2024.2369176 | - |
dc.identifier.bibliographicCitation | Renal failure, v.46, no.2 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 001253098500001 | - |
dc.identifier.scopusid | 2-s2.0-85196988241 | - |
dc.citation.number | 2 | - |
dc.citation.title | Renal failure | - |
dc.citation.volume | 46 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Acute kidney injury | - |
dc.subject.keywordAuthor | Wnt5a | - |
dc.subject.keywordAuthor | major adverse kidney event | - |
dc.subject.keywordAuthor | renal recovery | - |
dc.subject.keywordAuthor | sepsis | - |
dc.subject.keywordPlus | INTERNATIONAL CONSENSUS DEFINITIONS | - |
dc.subject.keywordPlus | SERUM CREATININE | - |
dc.subject.keywordPlus | AKI | - |
dc.subject.keywordPlus | SEPSIS | - |
dc.subject.keywordPlus | VALUES | - |
dc.subject.keywordPlus | PATHOGENESIS | - |
dc.subject.keywordPlus | RECOVERY | - |
dc.subject.keywordPlus | DISEASE | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.